Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
8.17
+0.01 (0.12%)
At close: Mar 6, 2026, 4:00 PM EST
8.02
-0.15 (-1.84%)
After-hours: Mar 6, 2026, 6:58 PM EST
Fulcrum Therapeutics Market Cap
Fulcrum Therapeutics has a market cap or net worth of $544.12 million as of March 6, 2026. Its market cap has increased by 162.02% in one year.
Market Cap
544.12M
Enterprise Value
198.26M
1-Year Change
162.02%
Ranking
Category
Stock Price
$8.17
Market Cap Chart
Since July 18, 2019, Fulcrum Therapeutics's market cap has increased from $301.64M to $544.12M, an increase of 80.39%. That is a compound annual growth rate of 9.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 544.12M | -27.07% |
| Dec 31, 2025 | 746.12M | 194.32% |
| Dec 31, 2024 | 253.51M | -39.25% |
| Dec 29, 2023 | 417.30M | 10.13% |
| Dec 30, 2022 | 378.93M | -47.15% |
| Dec 31, 2021 | 716.95M | 124.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Design Therapeutics | 590.71M |
| Allogene Therapeutics | 568.57M |
| Forte Biosciences | 566.33M |
| uniQure | 563.12M |
| CorMedix | 560.98M |
| Contineum Therapeutics | 542.83M |
| Rigel Pharmaceuticals | 537.82M |
| Altimmune | 534.74M |